Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy-Reference-Cited by-同舟云学术

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy

Published:2017-02 Issue: Volume:124 Page:57-65
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Owens David R.,Traylor Louise,Mullins Peter,Landgraf Wolfgang

Funder

Sanofi, Paris, France

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference19 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan – 2015;Handelsman;Endocr Pract,2015

3. Standards of medical care in diabetes – 2016;American Diabetes Association;Diabetes Care,2016

4. Agency for Healthcare Research and Quality. Premixed insulin analogues. A comparison with other treatments for type 2 diabetes ; 2009 [accessed 07.06.16].

5. Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: a pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials;Owens;Diabetes Res Clin Pract,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Efficacy and Safety of Commercially Available Fixed-Ratio Combinations of Insulin Degludec/Liraglutide and Insulin Glargine/Lixisenatide: A Network Meta-analysis;Canadian Journal of Diabetes;2023-06

2. Issues of insulin therapy for type 2 diabetes and ways to solve them;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-06-01

3. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023;Diabetes Care;2022-12-12

4. The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes;Expert Opinion on Pharmacotherapy;2022-06-28

5. Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes;Journal of Clinical Medicine Research;2022-01